Description
Kinerase Pro+Therapy Daily Defense Cream with SPF 30 is infused with Kinetin, and Zeatin, to visibly improve the appearance of wrinkles, aging and sun-damaged skin. Kinerase Pro+Therapy Daily Defense Cream SPF 30 is a gentle and effective non-prescription product that delivers anti-aging treatment, sun protection and moisture in a single application that does not smell or feel like a SPF. The non-comedogenic, hypoallergenic, fragrance-free and dye-free formula is non-irritating and ideal for sensitive skin, including those with dermatitis, eczema, and rosacea. Kinerase Pro+Therapy Daily Defense Cream with SPF 30 protects the skin from harmful UVA and UVB rays that cause premature aging, hyper pigmentation, and skin cancer. It offers all of the benefits of Kinerase Pro+Therapy Cream by visibly improving the appearances of fine lines and wrinkles. It helps hydrate dry, rough skin, minimizes the appearance of freckles and brown spots, and lessens the look of blotchy, uneven skin tone. Proprietary concentration of Kinetin and Zeatin to improve more severe, visible signs of aging. • Avobenzone provides protection against UVA rays. • Homosalate absorbs UVB rays. • Octocrylene, a chemical UVB sunscreen with strong water resistant properties. Directions: Apply in the morning to clean face. Net Weight: 2.8 oz. Ingredients: Water, Hexyldecanol, Propylene Glycol, Stearic Acid, Isopropyl Myristate, Glyceryl Caprate, Glyceryl Stearate, PEG-100 Stearate, Cetyl Alcohol, Carthamus Tinctorius (Safflower) Seed Oil, Styrene/Acrylates Copolymer, PEG-5 Soy Sterol, 1, 2-Hexanediol, Caprylyl Glycol, Ethylhexylglycerin, Dimethicone, Phenoxyethanol, Trethanolamine, Acrylates/C 10-30 Alkyl Acrylate Crosspolymer, Tetrasodium EDTA, Xanthan Gum, Soluble Collagen, Kinetin, Panthenol, Ascorbic Acid, Hydrolyzed Elastin, Zeatin.
Ingredients
Find the best deals
- N/A Beauty Bridge http://www.beautybridge.com
Sending...
This product was successfully sent to your friend!
There was an error, please try later...
Facebook
Twitter
Ask a question or leave a comment
0 comments